Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Camara-Lemarroy

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis and Related Disorders|October 1, 2023
The role of autophagy protein Atg5 in multiple sclerosisMaria-Elizabeth Baeva, Carlos Camara-Lemarroy
Neurology(R) Neuroimmunology & Neuroinflammation|April 6, 2018
Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMSSeraj Makkawi, Carlos Camara-Lemarroy, Luanne Metz
Journal of Neuroimmunology|February 6, 2022
Serum HGF and APN2 are associated with disability worsening in SPMSIsabelle Tottenham, Marcus Koch, Carlos Camara-Lemarroy
Frontiers in Neurology|June 13, 2025
Progression independent of relapsing biology in multiple sclerosis: a real-word studyHeather Y F Yong, Carlos Camara-Lemarroy
Seminars in Neurology|August 10, 2023
Gastrointestinal Dysfunction in StrokeHeather Y F Yong, Aravind Ganesh, Carlos Camara-Lemarroy
Journal of Neuroimmunology|December 29, 2023
Biomarkers of disability worsening in inactive primary progressive multiple sclerosisMaria-Elizabeth Baeva, Isabelle Tottenham, Marcus Koch, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 17, 2021
Multiple Immune-Related Adverse Event Overlap in Two Patients Treated with PembrolizumabJessica D Jenkins, Carlos Camara-Lemarroy, Jeffrey T Joseph, et al.
European Journal of Neurology|October 10, 2022
Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosisCarlos Camara-Lemarroy, Claudia Silva, Jit Gohill, et al.
Parkinson'S Disease|October 27, 2018
Accuracy of Markerless 3D Motion Capture Evaluation to Differentiate between On/Off Status in Parkinson's Disease after Deep Brain StimulationHector R Martinez, Alexis Garcia-Sarreon, Carlos Camara-Lemarroy, et al.
Journal of Neuroimmunology|June 8, 2019
Domperidone-induced elevation of serum prolactin levels and immune response in multiple sclerosisMarcus W Koch, Wei-Qiao Liu, Carlos Camara-Lemarroy, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|October 1, 2023
The role of autophagy protein Atg5 in multiple sclerosisMaria-Elizabeth Baeva, Carlos Camara-Lemarroy
Neurology(R) Neuroimmunology & Neuroinflammation|April 6, 2018
Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMSSeraj Makkawi, Carlos Camara-Lemarroy, Luanne Metz
Journal of Neuroimmunology|February 6, 2022
Serum HGF and APN2 are associated with disability worsening in SPMSIsabelle Tottenham, Marcus Koch, Carlos Camara-Lemarroy
Frontiers in Neurology|June 13, 2025
Progression independent of relapsing biology in multiple sclerosis: a real-word studyHeather Y F Yong, Carlos Camara-Lemarroy
Seminars in Neurology|August 10, 2023
Gastrointestinal Dysfunction in StrokeHeather Y F Yong, Aravind Ganesh, Carlos Camara-Lemarroy
Journal of Neuroimmunology|December 29, 2023
Biomarkers of disability worsening in inactive primary progressive multiple sclerosisMaria-Elizabeth Baeva, Isabelle Tottenham, Marcus Koch, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 17, 2021
Multiple Immune-Related Adverse Event Overlap in Two Patients Treated with PembrolizumabJessica D Jenkins, Carlos Camara-Lemarroy, Jeffrey T Joseph, et al.
European Journal of Neurology|October 10, 2022
Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosisCarlos Camara-Lemarroy, Claudia Silva, Jit Gohill, et al.
Parkinson'S Disease|October 27, 2018
Accuracy of Markerless 3D Motion Capture Evaluation to Differentiate between On/Off Status in Parkinson's Disease after Deep Brain StimulationHector R Martinez, Alexis Garcia-Sarreon, Carlos Camara-Lemarroy, et al.
Journal of Neuroimmunology|June 8, 2019
Domperidone-induced elevation of serum prolactin levels and immune response in multiple sclerosisMarcus W Koch, Wei-Qiao Liu, Carlos Camara-Lemarroy, et al.
Pageof 2